HALOPERIDOL INJECTION

The Defense Logistics Agency awarded a single-line delivery order under contract SPE2DX25D9822 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the supply of HALOPERIDOL INJECTION, identified by NSN 6505016945455, at a fixed unit price of $40.09, resulting in a total contract value of $40.09. The award was issued on July 17, 2026, as a firm-fixed-price delivery order with no quantity variance permitted, reflecting a low-value, commodity-style procurement typical of DLA’s medical supply chain operations. Deliveries are to be shipped FOB destination, with the primary delivery point at Electric Boat Corporation in North Stonington, Connecticut, and an alternate address in Groton, Connecticut, while the contractor is responsible for all freight and delivery costs. Packaging must be delivered via traceable means with parcel post prohibited, and all shipments must be clearly labeled with contract identifiers SPE2DX-25-D-9822 and SPE2D2-26-F-3057, along with tracking number N2716461902J21. No specific preservation, MIL-STD, or technical specifications are mandated, and inspection and acceptance occur at the destination by the government. The awardee has self-certified as a small business, small disadvantaged business, and women-owned business, triggering compliance obligations under FAR 19.102 and 19.1502, including SAM registration and potential subcontracting reporting. Payment is handled through the Defense Finance and Accounting Service using code SL4701, with remittance to P.O. Box 182317, Columbus, Ohio. Contracting officer Lisa Quinn and local administrator Jayne Do serve as the primary points of contact, though no formal COR or COTR is designated. The order contains no standard FAR or DFARS clauses, no attachments, no special requirements, and no evaluation factors, consistent with its nature as a streamlined, administrative delivery order issued against a pre-existing master contract for a standardized pharmaceutical item.